
Saatvik Green Energy lists at 1% below issue price; learn more about IPO performance and sector prospects now.
GK Energy lists on Dalal Street at a strong premium after nearly 90x IPO subscription – discover the latest on…
Markets today at open, September 26: Nifty opens lower as new US tariffs weigh on markets; track top gainers and…
JLR begins phased recovery after $2.4B cyberattack, restoring key digital systems and operations—track Tata Motors shares for updates.
Check your Jaro Institute IPO allotment status online today and get the latest listing updates – find out your share…
Pace Digitek IPO opens with a 12% GMP buzz; explore investment details and growth plans before the offer closes on…
What to watch for trade today, September 26: GIFT Nifty traded lower, indicating a negative start for Indian indices. Asian…
Stocks to watch today, September 26: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…
Check your Anand Rathi Share IPO allotment status online now; find out if you’ve been allotted shares before the September…
Check your Seshaasai Technologies IPO allotment status online now and see if you’ve secured shares before the September 30 listing.
Markets today at close, September 25: Nifty plunges below 24,900 and Sensex drops 555 points as markets fall for fifth…
Motilal Oswal tips L&T, Gland Pharma, and Kotak Bank for up to 18% returns—see why these stocks could boost your…
Check your Atlanta Electricals IPO allotment status online now and prepare for the NSE, BSE listing on September 29!
Midday movers today, September 25: Track top movers like Hindustan Copper, Bharat Electronics, Tata Motors, and Fineotex today—see which stocks…
Check your Ganesh Consumer Products IPO allotment status online now and get ready for the listing on September 29!
Hindustan Copper shares soar 7% amid global supply constraints and rising copper prices—explore investment opportunities now!
Compare GMP, subscription, and listing details of Solarworld, Seshaasai, and Jaro Institute IPOs—get key insights before bidding closes today!
Discover why Nomura predicts a 25% downside for Glenmark Pharma despite its new cancer drug deal—read their analysis before investing!